Compare RCUS & CIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCUS | CIVI |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 2018 | 2011 |
| Metric | RCUS | CIVI |
|---|---|---|
| Price | $25.41 | $29.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 13 |
| Target Price | $28.88 | ★ $40.60 |
| AVG Volume (30 Days) | ★ 1.7M | 1.4M |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 6.71% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.86 |
| Revenue | $240,000,000.00 | ★ $4,711,808,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.35 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.50 | $22.79 |
| 52 Week High | $26.40 | $55.35 |
| Indicator | RCUS | CIVI |
|---|---|---|
| Relative Strength Index (RSI) | 71.57 | 55.89 |
| Support Level | $24.32 | $26.70 |
| Resistance Level | $26.40 | $31.40 |
| Average True Range (ATR) | 1.30 | 1.03 |
| MACD | 0.01 | 0.26 |
| Stochastic Oscillator | 82.78 | 69.15 |
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.